ADIPOQ and chronic kidney disease: Multivariable-adjusted associations between natural log-transformed fibroblast growth factor-23 and natural log-transformed markers of insulin resistance (resistin; adiponectin; homeostatic model assessment of insulin resistance, HOMA-IR) in the overall sample and by chronic kidney disease (CKD) status (where interaction detected).